By contrast, other studies have shown a correlation between high SOX2 expression and negative lymph node status in HNSCC patients [41, 42], as well as a favorable prognosis in NSCLC [43], gastric cancer [44] and HNSCC patients [42]. The gene discussed is SOX2; the disease is head and neck squamous cell carcinoma.